Ms. Sarah Jayne Fisch, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 262 Gillespie St, Pine Bush, NY 12566 Phone: 845-616-2345 |
Jennifer M Harp, M.S. ED. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5237 Searsville Rd, Pine Bush, NY 12566 Phone: 845-800-6704 |
Connie Lynn Henke, S.L.P. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 156 Route 302, Pine Bush, NY 12566 Phone: 845-744-2031 |
Melina Wilson, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7 Van Keuren Ave, Pine Bush, NY 12566 Phone: 845-313-9110 |
Ms. Shannon Worth, MS CCC S/LP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Maple Ave, Pine Bush, NY 12566 Phone: 845-283-0905 |
Miss Bethany G Unterberger, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Hardenburgh Rd, Pine Bush, NY 12566 Phone: 845-551-9443 |
Allison Webster Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 27 Eskew Ct, Pine Bush, NY 12566 Phone: 845-978-6630 |
News Archive
In a study that helps to deconstruct how olfaction is encoded in the brain, neuroscientists at University of California, San Diego School of Medicine have identified a type of neuron that appears to help tune, amplify and dampen neuronal responses to chemosensory inputs from the nasal cavity.
Scientists at The Australian National University are a step closer to understanding the rare Hartnup disorder after discovering a surprising link between blood pressure regulation and nutrition that could also help to shed light on intestinal and kidney function.
Healthcare and opthalmology practices can manage Electronic Health Records with confidence and ease, thanks to practice management solution provider ManagementPlus. A pioneer in advanced EHR solutions, ManagementPlus continues to uphold its leadership position with today's announcement that the company's flagship product, ManagementPlus EHR 5.0, is a pre-market and ePrescribing conditionally CCHIT Certified 2011 Ambulatory EHR.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.
› Verified 9 days ago